Agree, Umi. Nasdaq provides much more opportunity to use different strategies. Long term on the ASX for me is generally called escrow
It's a shame that investing in the outcomes of molecules is basically ~25% less COS than betting black or red on the roulette wheel. Happy to use a VC approach with shells, where downside from entry is usually minimal but VCs usually own 8-9 trainwrecks for every winner with bios and impossible to manage risk.
What are you looking at for 2019?
- Forums
- Commodities
- Biotech Analysts $4M pa
Agree, Umi. Nasdaq provides much more opportunity to use...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)